Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: HERBOVIR SYRUP
(Ayush approved formulation): Dose: 10 ml thrice daily
Dosage form: Syrup
Route: Orally
Time of Administration: Morning,After noon and night after meal
Total duration:
Sponsors
Venkat Pharma
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects aged 18-65 years of age and of either sex 2.Subjects who are willing to give consent to the study 3.COVID-19 positive clinical symptoms and (subsequently) confirmedby the current recommended confirmatory test. 4.Mild to moderate clinical disease 5.Can take oral medicines 6.Subject willing to abide by and comply with the study protocol
Exclusion criteria
Exclusion criteria: 1.Age less than 18 years and more than 65 years 2.Pregnancy and lactation 3.Severe or complicated course of COVID-19 disease 4.Presence of acute hypoxic respiratory failure/ need for Intensive care unit (ICU) stay/Patients who need mechanical ventilation. 5.Subjects taking steroid treatment and or any kind ofimmunosuppressive therapy 6.Any uncontrolled systemic disease, infection 7.Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or Renal disease or any other disorder. 8.Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in LDH, TLC, CRP, D-DIMER and RT PCR from baseline to end of the studyTimepoint: Day 0 and End of the study (Day 7 to 14) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Adverse events (AEs), frequency and severity 2.Number of subjects who discontinue study due to adverse events 3.Changes in vital parameters and safety laboratory parameters Timepoint: Day 0 and Day 14 | — |
Countries
India
Contacts
Public ContactSri H Srinivas
Venkat Pharma
Outcome results
None listed